These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 21150524)
1. The role of hepatocyte growth factor/c-Met system in keloid pathogenesis. Mukhopadhyay A; Fan S; Dang VD; Khoo A; Ong CT; Lim IJ; Phan TT J Trauma; 2010 Dec; 69(6):1457-66. PubMed ID: 21150524 [TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta1-antisense modulates the expression of hepatocyte growth factor/scatter factor in keloid fibroblast cell culture. Naim R; Naumann A; Barnes J; Sauter A; Hormann K; Merkel D; Aust W; Braun T; Bloching M Aesthetic Plast Surg; 2008 Mar; 32(2):346-52. PubMed ID: 18087663 [TBL] [Abstract][Full Text] [Related]
3. Increased c-Met phosphorylation is related to keloid pathogenesis: implications for the biological behaviour of keloid fibroblasts. Jin Z Pathology; 2014 Jan; 46(1):25-31. PubMed ID: 24300717 [TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor suppresses transforming growth factor-beta-1 and type III collagen in human primary renal fibroblasts. Mou S; Wang Q; Shi B; Gu L; Ni Z Kaohsiung J Med Sci; 2009 Nov; 25(11):577-87. PubMed ID: 19858036 [TBL] [Abstract][Full Text] [Related]
5. Syndecan-2 and decorin: proteoglycans with a difference--implications in keloid pathogenesis. Mukhopadhyay A; Wong MY; Chan SY; Do DV; Khoo A; Ong CT; Cheong HH; Lim IJ; Phan TT J Trauma; 2010 Apr; 68(4):999-1008. PubMed ID: 20386290 [TBL] [Abstract][Full Text] [Related]
6. The role of stem cell factor and c-KIT in keloid pathogenesis: do tyrosine kinase inhibitors have a potential therapeutic role? Mukhopadhyay A; Do DV; Ong CT; Khoo YT; Masilamani J; Chan SY; Vincent AS; Wong PK; Lim CP; Cao X; Lim IJ; Phan TT Br J Dermatol; 2011 Feb; 164(2):372-86. PubMed ID: 20846303 [TBL] [Abstract][Full Text] [Related]
7. c-Met responsiveness of isolated hepatocytes evaluated in an in vitro de-differentiation model. Boost KA; Kim HJ; Engl T; Oppermann E; Jonas D; Oertl A; Blaheta RA Int J Mol Med; 2006 Mar; 17(3):475-82. PubMed ID: 16465395 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth. Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613 [TBL] [Abstract][Full Text] [Related]
9. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Nakamura T; Matsumoto K; Kiritoshi A; Tano Y; Nakamura T Cancer Res; 1997 Aug; 57(15):3305-13. PubMed ID: 9242465 [TBL] [Abstract][Full Text] [Related]
10. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver. Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708 [TBL] [Abstract][Full Text] [Related]
11. Influence of hepatocyte growth factor secreted from fibroblasts on the growth and invasion of scirrhous gastric cancer. Murakami N; Koufuji K; Shirouzu K Int Surg; 2001; 86(3):151-7. PubMed ID: 11996071 [TBL] [Abstract][Full Text] [Related]
12. Expression and localization of HGF and met in Wilms' tumours. Alami J; Williams BR; Yeger H J Pathol; 2002 Jan; 196(1):76-84. PubMed ID: 11748645 [TBL] [Abstract][Full Text] [Related]
14. Expression of hepatocyte growth factor and c-Met after spinal cord injury in rats. Shimamura M; Sato N; Sata M; Wakayama K; Ogihara T; Morishita R Brain Res; 2007 Jun; 1151():188-94. PubMed ID: 17425951 [TBL] [Abstract][Full Text] [Related]
15. High expression of Met/hepatocyte growth factor receptor suppresses tumorigenicity in NCI-H1264 lung carcinoma cells. To C; Seiden I; Liu N; Wigle D; Tsao MS Exp Cell Res; 2002 Feb; 273(1):45-53. PubMed ID: 11795945 [TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4. Matsumoto K; Nakamura T; Sakai K; Nakamura T Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008 [TBL] [Abstract][Full Text] [Related]
17. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway. Tiran Z; Oren A; Hermesh C; Rotman G; Levine Z; Amitai H; Handelsman T; Beiman M; Chen A; Landesman-Milo D; Dassa L; Peres Y; Koifman C; Glezer S; Vidal-Finkelstein R; Bahat K; Pergam T; Israel C; Horev J; Tsarfaty I; Ayalon-Soffer M Clin Cancer Res; 2008 Jul; 14(14):4612-21. PubMed ID: 18628476 [TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression. Colombo ES; Menicucci G; McGuire PG; Das A Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1793-800. PubMed ID: 17389513 [TBL] [Abstract][Full Text] [Related]
19. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy. Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398 [TBL] [Abstract][Full Text] [Related]
20. Immunolocalization of hepatocyte growth factor and its receptor (c-Met) during mouse liver development. Ishikawa KS; Masui T; Ishikawa K; Shiojiri N Histochem Cell Biol; 2001 Nov; 116(5):453-62. PubMed ID: 11735009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]